SPC506
Acoramidis og/eða lyfjafræðilega viðunandi salt þar af, sérstaklega acoramidisvetnisklóríð
Status:
UmsóknApplication date:
19.3.2025Application published:
15.4.2025Grant published:
15.9.2025
Max expiry date:
17.12.2038Medicine name:
BEYONTTRAMedicine for children:
No
Timeline
Today
19.3.2025Application
15.4.2025Publication
15.9.2025Registration
17.12.2038Expires
Marketing license
Foreign authorization number:
EU/1/24/1906Date:
10.3.2025
Owner
Name:
The Board of Trustees of the Leland Stanford Junior UniversityAddress:
Office of the General Counsel, Building 170, 3rd Floor, Main Quad, P.O. Box 20386, Stanford, California 94305-2038 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2934514
Deadlines
TypeDeadline until
Type: Formgallafrestur, fyrsti
Deadline until: 07.08.2025